(ATRO) Astronics - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 2.634m USD | Total Return: 233.5% in 12m
Industry Rotation: -3.8
Avg Turnover: 29.4M USD
Peers RS (IBD): 95.4
EPS Trend: 77.0%
Qual. Beats: 1
Rev. Trend: 56.0%
Qual. Beats: 0
Warnings
P/E ratio 91.1
Volatile
Tailwinds
No distinct edge detected
Astronics Corporation (ATRO) designs and manufactures products for the aerospace, defense, and electronics sectors. The company operates globally, with significant presence in North America, Asia, and Europe. The aerospace and defense sector is characterized by long product development cycles and high regulatory hurdles.
The company has two primary segments: Aerospace and Test Systems. The Aerospace segment provides various aircraft components, including lighting, power generation, and avionics. This segment serves original equipment manufacturers (OEMs) and aircraft operators, including commercial airlines and military branches.
The Test Systems segment develops automated test equipment and simulation devices. This segment supports aerospace, defense, communications, and mass transit industries. Customers include OEMs and prime government contractors. The business model for test systems often involves recurring revenue from maintenance and support services.
For more detailed analysis, consider exploring ValueRays comprehensive reports on ATRO.
- Aerospace OEM demand dictates revenue for aircraft components
- Defense spending impacts Test Systems segment orders
- Supply chain disruptions increase manufacturing costs
- Commercial airline recovery drives cabin electronics sales
| Net Income: 29.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.79 > 1.0 |
| NWC/Revenue: 34.39% < 20% (prev 33.95%; Δ 0.44% < -1%) |
| CFO/TA 0.11 > 3% & CFO 75.5m > Net Income 29.4m |
| Net Debt (360.2m) to EBITDA (66.2m): 5.44 < 3 |
| Current Ratio: 3.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.5m) vs 12m ago 8.70% < -2% |
| Gross Margin: 29.94% > 18% (prev 0.25%; Δ 2.97k% > 0.5%) |
| Asset Turnover: 127.2% > 50% (prev 122.6%; Δ 4.60% > 0%) |
| Interest Coverage Ratio: 3.53 > 6 (EBITDA TTM 66.2m / Interest Expense TTM 12.6m) |
| A: 0.42 (Total Current Assets 437.7m - Total Current Liabilities 141.3m) / Total Assets 706.7m |
| B: 0.31 (Retained Earnings 216.7m / Total Assets 706.7m) |
| C: 0.07 (EBIT TTM 44.3m / Avg Total Assets 677.7m) |
| D: 0.38 (Book Value of Equity 212.7m / Total Liabilities 566.6m) |
| Altman-Z'' Score: 4.59 = AA |
| DSRI: 0.99 (Receivables 204.7m/191.4m, Revenue 862.1m/795.4m) |
| GMI: 0.82 (GM 29.94% / 24.63%) |
| AQI: 1.01 (AQ_t 0.18 / AQ_t-1 0.18) |
| SGI: 1.08 (Revenue 862.1m / 795.4m) |
| TATA: -0.07 (NI 29.4m - CFO 75.5m) / TA 706.7m) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
Over the past week, the price has changed by +5.89%, over one month by +10.71%, over three months by +6.26% and over the past year by +233.45%.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 86.6 | 13.8% |
P/E Forward = 27.1739
P/S = 3.0548
P/B = 17.7954
P/EG = 1.4507
Revenue TTM = 862.1m USD
EBIT TTM = 44.3m USD
EBITDA TTM = 66.2m USD
Long Term Debt = 334.5m USD (from longTermDebt, last quarter)
Short Term Debt = 5.80m USD (from shortTermDebt, last quarter)
Debt = 378.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 360.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.99b USD (2.63b + Debt 378.4m - CCE 18.2m)
Interest Coverage Ratio = 3.53 (Ebit TTM 44.3m / Interest Expense TTM 12.6m)
EV/FCF = 68.26x (Enterprise Value 2.99b / FCF TTM 43.9m)
FCF Yield = 1.47% (FCF TTM 43.9m / Enterprise Value 2.99b)
FCF Margin = 5.09% (FCF TTM 43.9m / Revenue TTM 862.1m)
Net Margin = 3.41% (Net Income TTM 29.4m / Revenue TTM 862.1m)
Gross Margin = 29.94% ((Revenue TTM 862.1m - Cost of Revenue TTM 604.0m) / Revenue TTM)
Gross Margin QoQ = 33.31% (prev 30.51%)
Tobins Q-Ratio = 4.24 (Enterprise Value 2.99b / Total Assets 706.7m)
Interest Expense / Debt = 0.90% (Interest Expense 3.39m / Debt 378.4m)
Taxrate = 8.15% (2.63m / 32.2m)
NOPAT = 40.7m (EBIT 44.3m * (1 - 8.15%))
Current Ratio = 3.10 (Total Current Assets 437.7m / Total Current Liabilities 141.3m)
Debt / Equity = 2.70 (Debt 378.4m / totalStockholderEquity, last quarter 140.1m)
Debt / EBITDA = 5.44 (Net Debt 360.2m / EBITDA 66.2m)
Debt / FCF = 8.21 (Net Debt 360.2m / FCF TTM 43.9m)
Total Stockholder Equity = 196.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.33% (Net Income 29.4m / Total Assets 706.7m)
RoE = 14.92% (Net Income TTM 29.4m / Total Stockholder Equity 196.8m)
RoCE = 8.34% (EBIT 44.3m / Capital Employed (Equity 196.8m + L.T.Debt 334.5m))
RoIC = 9.17% (NOPAT 40.7m / Invested Capital 443.8m)
WACC = 8.59% (E(2.63b)/V(3.01b) * Re(9.71%) + D(378.4m)/V(3.01b) * Rd(0.90%) * (1-Tc(0.08)))
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.04%
[DCF] Terminal Value 68.01% ; FCFF base≈35.2m ; Y1≈23.1m ; Y5≈10.6m
[DCF] Fair Price = N/A (negative equity: EV 189.3m - Net Debt 360.2m = -170.8m; debt exceeds intrinsic value)
EPS Correlation: 77.00 | EPS CAGR: 36.29% | SUE: 0.86 | # QB: 1
Revenue Correlation: 56.03 | Revenue CAGR: 21.35% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.007 | Chg30d=+0.027 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=2.64 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+3 | Growth EPS=+31.5% | Growth Revenue=+12.7%
EPS next Year (2027-12-31): EPS=3.14 | Chg7d=+0.038 | Chg30d=+0.212 | Revisions Net=+3 | Growth EPS=+18.9% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.6% (Discount Rate 9.7% - Earnings Yield 1.1%)
[Growth] Growth Spread = +8.0% (Analyst 16.6% - Implied 8.6%)